Jul. 14 at 1:45 PM
$CVKD Guidehouse, an AI-led professional services firm delivering advisory, technology, and managed services to the commercial and government sectors, underscores the significant clinical and economic burden for LVAD patients who require chronic oral anticoagulation. Key findings include:
Major bleeds remain a primary cost driver, with average hospitalization costs (per event) of
$54,100 for intracranial hemorrhage,
$26,900 for gastrointestinal bleeds, and
$36,600 for other major bleeds.
